These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


79 related items for PubMed ID: 6115301

  • 1. The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the rat.
    Bhargava HN.
    Life Sci; 1981 Jul 06; 29(1):45-51. PubMed ID: 6115301
    [No Abstract] [Full Text] [Related]

  • 2. The effects of peptides on tolerance to the cataleptic and hypothermic effects of morphine in the rat.
    Bhargava HN.
    Neuropharmacology; 1981 Apr 06; 20(4):385-90. PubMed ID: 6117032
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the rat.
    Bhargava HN.
    J Pharmacol Exp Ther; 1981 Aug 06; 218(2):404-8. PubMed ID: 6114170
    [Abstract] [Full Text] [Related]

  • 4. Inability of cyclo (LEU-GLY) to facilitate the development of tolerance to and physical dependence on morphine in the rat.
    Bhargava HN.
    Life Sci; 1980 Sep 22; 27(12):1075-81. PubMed ID: 6106875
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.
    Mycroft FJ, Wei ET.
    Peptides; 1984 Sep 22; 5(5):883-7. PubMed ID: 6150468
    [Abstract] [Full Text] [Related]

  • 8. The effects of centrally acting peptides on the chronic actions of buprenorphine in the rat.
    Bhargava HN.
    NIDA Res Monogr; 1982 Apr 22; 41():134-40. PubMed ID: 6126811
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of melanotrophin release inhibiting factor (MIF) and cyclo (Leu-Gly) on the tolerance to morphine-induced antinociception in the rat: a dose-response study.
    Bhargava HN.
    Br J Pharmacol; 1981 Apr 22; 72(4):707-14. PubMed ID: 6116510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypothalamic peptide hormone, prolyl-leucyl-glycinamide and analog, inhibit tolerance to the analgesic and locomotor depressant but not to the locomotor stimulant effects of morphine in the mouse.
    Bhargava HN.
    Neuropharmacology; 1982 Mar 22; 21(3):227-33. PubMed ID: 6122186
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhanced response to apomorphine in rats treated with multiple injections of human beta endorphin and its blockade by Pro-Leu-Gly-NH2 and cyclo (Leu-Gly).
    Bhargava HN.
    Life Sci; 1981 Nov 09; 29(19):1945-9. PubMed ID: 6118804
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Blockade of brain dopamine receptors antagonizes the anti-immobility effect of MIF-1 and Tyr-MIF-1 in rats.
    Pulvirenti L, Kastin AJ.
    Eur J Pharmacol; 1988 Jul 07; 151(2):289-92. PubMed ID: 2901971
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.